444 third-party lab reports published 3 for the price of 2 on compound vials and capsules — put any 3 in your cart and the cheapest one is free, automatically. Solvents and lab supplies excluded. Ends Monday night. For research use only. 99.59% median purity across 251 lots Defense, VA, Federal and Public safety: your VerifyPass code adds 5% on top of 3 for the price of 2 · get verified 239 / 239 lots pass sterility

‹ Certificates Tesa + CJC + Ipa 3x Blend Lot 1718

Lab report (Certificate of Analysis, COA)

Tesa + CJC + Ipa 3x Blend · 6.18mg/2.96mg/3.16mg

Batch 1718 · tested July 23, 2026 (59 days ago) · released July 27, 2026 Discontinued variant

All tests passed

Batch
#1718 14 tests
Mass
6.18mg/2.96mg/3.16mg
Purity
>99.00%
Issuing lab accreditation
Vanguard · ISO 17025:2017 / A2LA #6377.01.01

3 units tested for purity, each printed >99.00% · net peptide content · tesamorelin 6.12 / 6.22 / 6.20 mg · net peptide content · cjc-1295 2.91 / 3.01 / 2.95 mg · net peptide content · ipamorelin 3.08 / 3.20 / 3.19 mg

Conformity: Units agree — every reported unit passed on all 12 test rows · purity: every unit above the same 99.00% bound, no difference reported · content spread (Tesamorelin) 1.6% within the house limit · content spread (CJC-1295) 3.4% within the house limit · content spread (Ipamorelin) 3.8% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-07-23

Vanguard · issuing labEagle Analytical · sterility

Notes

Content audit 9 Sep 2026: lab id (blank) → V260703-5 001. Certificate prints: prints compound "Tesamorelin/CJC-1295/Ipamorelin", lot "1718", lab id "V260703-5 001", content Tesamorelin: 6.12/6.22/6.20 mg; CJC-1295

Reports for this lot

  1. Vanguard Laboratory this report · tested July 23, 2026 · 12 results · QA approvalVanguard · issuing labEagle Analytical · sterilityAll tests passed

Test by test

12 results on the report · 5 rows computed from the per-unit values · 2 labs · each test used up to 5 vials from this lot (rows are not added together) · every row names the chapter or house rule it follows

PurityPass
3 of 3 pass · 3 units · USP <621> (procedural chapter)
Purity consistency between unitsWithin house limit
3 units, each above 99.00% (the lab's reporting bound) · every unit printed the same bound, so the report shows no difference between units (the bound allows at most 1.00 pt) · house limit · caution past 0.50 pt, outside past 1.00 pt · per-unit USP <621> results
Net peptide content (assay) · TesamorelinWithin limits
avg 6.18 mg · 3 units · USP <621> (procedural chapter)
Net peptide content (assay) · CJC-1295Within limits
avg 2.96 mg · 3 units · USP <621> (procedural chapter)
Net peptide content (assay) · IpamorelinWithin limits
avg 3.16 mg · 3 units · USP <621> (procedural chapter)
Content consistency between units · TesamorelinWithin house limit
3 units: 6.12 / 6.22 / 6.20 mg · spread 0.10 mg, 1.6% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)
Content consistency between units · CJC-1295Within house limit
3 units: 2.91 / 3.01 / 2.95 mg · spread 0.10 mg, 3.4% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)
Content consistency between units · IpamorelinWithin house limit
3 units: 3.08 / 3.20 / 3.19 mg · spread 0.12 mg, 3.8% of the mean · house check · caution past 5%, outside past 10% · USP <905> is the compendial reference for between-unit uniformity (10 units; not claimable on 3)
Heavy metalsWithin limits
2 units · dose-scaled limits derived from USP <232> (limits chapter)
Residual solventsWithin limits
all non-detect · 1 unit · USP <467> (procedural chapter)
Trifluoroacetic acidWithin limits
all non-detect · 1 unit · house limit · ion chromatography, the lab's method; no compendial chapter for the method run · limit <0.10% (the lab's)
EndotoxinsPass
3 of 3 pass · 3 units · USP <85> (procedural chapter) · limit <5.00 EU/mg (the lab's)
Container closurePass
3 of 3 pass · 3 units · USP <1207> (informational chapter (1000-series))
SolubilityPass
3 of 3 pass · 3 units · house check · no compendial chapter
SterilityPass
5 of 5 pass · 5 units · USP <71> (procedural chapter)
SterilityPass
1 of 1 pass · 1 unit · USP <71> (reference) · a rapid viability test used as an alternative to the USP <71> growth test; USP <1223> is the validation framework (informational chapter) · at Eagle Analytical
ConformityUnits agree
every reported unit passed on all 12 test rows · purity: every unit above the same 99.00% bound, no difference reported · content spread (Tesamorelin) 1.6% within the house limit · content spread (CJC-1295) 3.4% within the house limit · content spread (Ipamorelin) 3.8% within the house limit · QA approval corroborates: Vanguard Laboratory, Tori Johnson, Operations Manager, 2026-07-23 · house check · agreement across all tests, unit to unit; QA approval corroborates

A chapter number names the method or limit a result follows; it does not describe the product. Chapters below 1000 are procedures or limits; 1000-series chapters are informational. USP <905> is the compendial test for between-unit uniformity: it assays 10 units, so a 3-unit certificate cannot yield its acceptance value — the content row is a house check with <905> named as the reference only.

Tested by Vanguard Laboratory · Eagle Analytical Services Inc. · Released July 27, 2026 · Verify: go.peptidology.co/goPsI9

Permanent URL: https://peptidology.co/coa/tesa-cjc-ipa-3x-blend-lot-1718/

For research use only. Not intended for diagnostic or therapeutic use.

This certificate has been viewed 65 times.